Cimiracemoside C
Cat. No.:YN420315
| 产品名称: | Cimiracemoside C |
| CAS No.: | 256925-92-5 |
| Chemical Name: | (3β,15α,16α,23R,24S)-16,23:16,24-Diepoxy-15,25-dihydroxy-9,19-cyclolanostan-3-yl α-L-arabinopyranoside; Cimigenol 3-O-α-L-Arabinopyranoside; Cimigenol 3-O-α-L-Arabinoside; Cimiracemoside C; |
| Synonyms: | Cimicifugoside M |
| 分子量: | 620.81 |
| 分子式: | C₃₅H₅₆O₉ |
| SMILES: | C[C@]12[C@@]3([H])[C@@]4(CC[C@@]1([C@]5([H])C(O[C@H](C(C)(O)C)[C@@]6([H])C[C@H]5C)(O6)[C@@H]2O)C)[C@@]7([C@@](C(C)([C@@H](O[C@@]8([H])[C@@H]([C@H]([C@@H](O)CO8)O)O)CC7)C)([H])CC3)C4 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Cimiracemoside C 是升麻中的有效成分,可激活AMPK,具有抗糖尿病的潜力。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Gorman, G. S., et al.: J. Pharm. Pharmacol., 65, 1014-1025 (2013)